Bill Details
S.1157 - 119th Congress
Status
Latest action
2026-06-09 - Held at the desk.
Introduced Date
2025-03-26
Policy Area
Health
Committees
View committees (1)
Sponsors
Cosponsors
7
0
0
AI Summary This summary was generated by AI from the bill text. AI can get information wrong.
This bill tells the Secretary of Health and Human Services, working with the Defense and Veterans Affairs departments, to review how the federal government studies, prevents, diagnoses, and treats lung cancer in women and in other groups that may be missed by current research. The goal is to find gaps in knowledge, improve screening, and look for better ways to spot and treat lung cancer earlier. It also asks the government to look at whether more research, public education, and updated screening efforts are needed. Within two years, the Secretary must report the results to Congress and explain what changes have been made or should be made.
- The review must focus on lung cancer in women and in people with few known risk factors, as well as ways to improve screening rates in groups recommended for screening by federal health experts.
- It must look at current research, ongoing federally funded studies, and where important knowledge gaps still exist.
- The bill calls for possible new research efforts, including teamwork across federal agencies, to study environmental and genetic causes, improve screening, and support better tools like biomarker testing.
- The report to Congress must include research findings, any changes already made, recommended next steps, and any barriers that make those changes hard to carry out.
Official Summaries
No summaries available
Current Full Text
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. 1157 Engrossed in Senate (ES)]
<DOC>
119th CONGRESS
2d Session
S. 1157
_______________________________________________________________________
AN ACT
To direct the Secretary of Health and Human Services to conduct a
review to evaluate the status of research on lung cancer in women and
underserved populations, and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Women and Lung Cancer Research and
Preventive Services Act of 2025''.
SEC. 2. INTERAGENCY REVIEW TO EVALUATE AND IDENTIFY OPPORTUNITIES TO
IMPROVE LUNG CANCER PREVENTION AND TREATMENT IN WOMEN.
(a) In General.--The Secretary of Health and Human Services, in
consultation with the Secretary of Defense and the Secretary of
Veterans Affairs, shall review and, as necessary and appropriate,
update Federal programs, activities, and strategic plans related to
lung cancer research, prevention, diagnosis, and treatment for purposes
of--
(1) identifying and addressing knowledge gaps and improving
health outcomes related to lung cancer in women and populations
with few known risk factors; and
(2) improving lung cancer screening rates among populations
recommended by the United States Preventive Services Task Force
to receive such screening.
(b) Content.--The review under subsection (a) shall include--
(1) a review of findings from research on lung cancer in
populations described in paragraphs (1) and (2) of subsection
(a), the status of ongoing federally funded research on lung
cancer in such populations, and knowledge gaps related to lung
cancer in such populations;
(2) consideration of additional research opportunities,
including through interagency collaboration and
multidisciplinary projects, that would--
(A) eliminate knowledge gaps in research on lung
cancer in women, including an evaluation of any
environmental and genomic factors that may be related
to the etiology of lung cancer in women;
(B) improve screening rates among populations
described in subsection (a)(2); or
(C) foster advances in technology and
interventions, including biomarker testing, to improve
lung cancer risk assessment, diagnosis, and treatment;
and
(3) a review of current public health strategies, and
consideration of alternative evidence-based strategies, related
to lung cancer screening and diagnosis, including an assessment
of the need for additional public awareness and education.
(c) Report.--Not later than 2 years after the date of the enactment
of this Act, the Secretary of Health and Human Services shall submit to
the Committee on Health, Education, Labor, and Pensions and the
Committee on Appropriations of the Senate and the Committee on Energy
and Commerce and the Committee on Appropriations of the House of
Representatives a report on the review conducted under subsection (a),
including--
(1) a summary of research findings, ongoing research
projects, and knowledge gaps described in subsection (b)(1);
(2) a description of any changes made by such Secretary or
the head of any other Federal agency to Federal programs,
activities, or strategic plans based on the findings of the
review; and
(3) any additional changes to Federal programs, activities,
or strategic plans recommended by the Secretary based on the
review, and any statutory or other barriers that impede
implementation of such changes.
Passed the Senate June 8, 2026.
Attest:
Secretary.
119th CONGRESS
2d Session
S. 1157
_______________________________________________________________________
AN ACT
To direct the Secretary of Health and Human Services to conduct a
review to evaluate the status of research on lung cancer in women and
underserved populations, and for other purposes.